Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NBIX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Neurocrine Biosciences Inc (NBIX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Neurocrine Biosciences (NBIX) trades at $154.49, up 1.16% on the day, amid a mixed technical and fundamental backdrop. The stock faces near-term pressure from a bearish technical signal and recent safety concerns over its Vykat XR drug, yet strong fundamentals are evident with a 39% year-over-year revenue growth in Q2 2026 and a net income margin of 20.91%. Recent earnings beats and a robust analyst consensus of 32 buys support the long-term growth narrative driven by its Ingrezza and Crenessity products.
The outlook for NBIX is cautiously optimistic, with significant upside potential reflected in the $208 consensus price target, but investors must weigh robust financial performance against drug safety risks and technical weakness. The key opportunity lies in the company's expanding portfolio and pipeline catalysts, while regulatory scrutiny and market volatility present near-term headwinds for shareholder value.
Read full analysis

Key Stats

  • Market Cap
    $15.53B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    -
  • Enterprise Value
    $15.54B
  • Div Yield
    -
  • Trading Activity
    -
$154.95
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Most Recent News

Content is generated by Aura AI

Gold breaks out of summer price channel, rallying alongside silver and mining stocks.

Gold has recently broken out of the price channel that had kept it stable since summer, sparking a rally that is also lifting silver and mining stocks. This movement is significant as gold and bonds are highly sensitive indicators of market imbalance...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

Google wins $10M auction for Spirit Airlines data to boost AI development

Google has won a $10 million bankruptcy auction for Spirit Airlines' internal business data and software, which includes around 100 million emails and 500 million Microsoft Teams messages. The data will be used to improve Google's products and AI mod...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
pluang ai news

Babcock & Wilcox rated STRONG BUY on growth from data center power solutions and major contracts.

Babcock & Wilcox (BW) is rated a strong buy due to its strategic position in providing fast, modular power solutions for data centers amid rising demand and grid limitations. The company secured a $2.4 billion Base Electron contract and has a $14 bil...

Market News
5 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $15.53B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $185.50
  • 52W Low
    $123.10
  • Typical Hold Time
    -
  • Enterprise Value
    $15.54B
  • Div Yield
    -
  • Trading Activity
    -
$154.95
52W Low: $123.1
12 Feb 2026
52W High: $185.5
30 Jul 2026

Track Neurocrine Biosciences Inc (NBIX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.1 and a high of $185.5, highlighting its annual price range. Buy and sell Neurocrine Biosciences Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!